- Entry
- $49.20
- Now
- $51.62 +4.9%
- Target
- —
- Score
- —
Eli Lilly (LLY) and Novo Nordisk (NVO) are both in the lead in the weight loss drug market, with LLY being the current number one. Both companies have injectable and oral drugs. The companies are moving in sharply contrasting financial directions. Their market capitalization is also widely divergent: LLY \~ €1.08 trillion (!) vs. NVO \~€199 billion. The projected sales for NVO look less good than for LLY. However, the P/E ratio's of both companies also widely differ: NVO approx. …
— ORIGINAL POST ·
The weight loss race: Eli Lilly vs. Novo Nordisk
· r/stocks
· Jun 30, 2026